NeuBase Therapeutics Inc (NBSE)
0.395
-0.02
(-5.05%)
USD |
NASDAQ |
May 02, 10:28
NeuBase Therapeutics Free Cash Flow (Quarterly): -2.003M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.003M |
| June 30, 2023 | -3.644M |
| March 31, 2023 | -3.461M |
| December 31, 2022 | -5.738M |
| September 30, 2022 | -6.667M |
| June 30, 2022 | -9.084M |
| March 31, 2022 | -8.341M |
| December 31, 2021 | -5.392M |
| September 30, 2021 | -5.784M |
| June 30, 2021 | -6.824M |
| March 31, 2021 | -3.73M |
| December 31, 2020 | -3.974M |
| September 30, 2020 | -3.922M |
| June 30, 2020 | -3.086M |
| March 31, 2020 | -1.909M |
| December 31, 2019 | -2.510M |
| September 30, 2019 | -1.146M |
| June 30, 2019 | -0.7046M |
| March 31, 2019 | -0.9812M |
| December 31, 2018 | -0.5668M |
| September 30, 2018 | -0.5966M |
| June 30, 2018 | -1.182M |
| March 31, 2018 | -3.519M |
| December 31, 2017 | -4.196M |
| September 30, 2017 | -5.275M |
| Date | Value |
|---|---|
| June 30, 2017 | -4.118M |
| March 31, 2017 | -3.968M |
| December 31, 2016 | -5.935M |
| September 30, 2016 | -5.034M |
| June 30, 2016 | -4.185M |
| March 31, 2016 | -3.444M |
| December 31, 2015 | -3.337M |
| September 30, 2015 | -2.211M |
| June 30, 2015 | -1.774M |
| March 31, 2015 | -4.155M |
| December 31, 2014 | -2.738M |
| September 30, 2014 | -1.578M |
| June 30, 2014 | -1.947M |
| March 31, 2014 | -0.5429M |
| December 31, 2013 | -1.293M |
| September 30, 2013 | -0.9244M |
| June 30, 2013 | -0.7279M |
| March 31, 2013 | -0.3762M |
| December 31, 2012 | -0.6611M |
| September 30, 2012 | -0.5198M |
| June 30, 2012 | -0.4247M |
| March 31, 2012 | -0.5852M |
| December 31, 2011 | -0.2576M |
| September 30, 2011 | -0.4088M |
| June 30, 2011 | -0.2296M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.084M
Minimum
Jun 2022
-0.7046M
Maximum
Jun 2019
-4.329M
Average
-3.826M
Median
Free Cash Flow (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | -2.309M |
| Stoke Therapeutics Inc | -20.88M |
| ABVC BioPharma Inc | -0.4795M |
| MAIA Biotechnology Inc | -3.992M |
| Aprea Therapeutics Inc | -3.747M |